Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Abbott partners with Novo Nordisk India to launch Extensior broadening access to Semaglutide (Ozempic) for advanced diabetes management.more...
Voting Results along with the Consolidated Scrutinizer s Report.more...
The company reported standalone net profit of Rs 375.96 crore for the quarter ended December 31 2025 as compared to Rs 360.78 crore in the same perio...more...
Unaudited Financial Results of the Company for the quarter ended December 31 2025.more...
Outcome of Board Meeting.more...
Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider...more...
As of December 2025 74.99% is owned by Foreign Promoters and 25.01% by Public. Institutional holds 9.19% (Insurance Companies 1.06%) and Non-Institut...more...
Postal Ballot Notice - Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirem...more...
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter end...more...
Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.more...
Appointment of Mr. Vivek Mohan (DIN : 00075006) as Additional (Non-Executive) Director with effect from January 1 2026.more...
Change in Senior Management Personnel.more...
Approval of Central Government for appointment of Managing Directormore...
The company reported standalone net profit of Rs 415.27 crore for the quarter ended September 30 2025 as compared to Rs 358.61 crore in the ...more...
Unaudited financial results for the quarter ended September 30 2025.more...
Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and appr...more...
As of September 2025 74.99% is owned by Foreign Promoters and 25.01% by Public. Institutional holds 9.27% (Insurance Companies 1.05%) and No...more...
Result of Postal Ballot.more...
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the qu...more...
BOARD MEETINGS Company Name : Supha Pharmachem Date : 30-03-2026